Cite
The Utility of Infliximab Therapeutic Drug Monitoring among Patients with Inflammatory Bowel Disease and Concerns for Loss of Response: A Retrospective Analysis of a Real-World Experience.
MLA
Mitchell, Robert A., et al. “The Utility of Infliximab Therapeutic Drug Monitoring among Patients with Inflammatory Bowel Disease and Concerns for Loss of Response: A Retrospective Analysis of a Real-World Experience.” Canadian Journal of Gastroenterology & Hepatology, vol. 2016, 2016, p. 5203898. EBSCOhost, https://doi.org/10.1155/2016/5203898.
APA
Mitchell, R. A., Shuster, C., Shahidi, N., Galorport, C., DeMarco, M. L., Rosenfeld, G., Enns, R. A., & Bressler, B. (2016). The Utility of Infliximab Therapeutic Drug Monitoring among Patients with Inflammatory Bowel Disease and Concerns for Loss of Response: A Retrospective Analysis of a Real-World Experience. Canadian Journal of Gastroenterology & Hepatology, 2016, 5203898. https://doi.org/10.1155/2016/5203898
Chicago
Mitchell, Robert A, Constantin Shuster, Neal Shahidi, Cherry Galorport, Mari L DeMarco, Gregory Rosenfeld, Robert A Enns, and Brian Bressler. 2016. “The Utility of Infliximab Therapeutic Drug Monitoring among Patients with Inflammatory Bowel Disease and Concerns for Loss of Response: A Retrospective Analysis of a Real-World Experience.” Canadian Journal of Gastroenterology & Hepatology 2016: 5203898. doi:10.1155/2016/5203898.